CenterBook Partners LP Purchases 73,473 Shares of Sotera Health Company $SHC

CenterBook Partners LP grew its position in Sotera Health Company (NASDAQ:SHC) by 94.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 151,529 shares of the company’s stock after acquiring an additional 73,473 shares during the quarter. CenterBook Partners LP owned about 0.05% of Sotera Health worth $2,673,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Capricorn Fund Managers Ltd bought a new position in shares of Sotera Health during the fourth quarter valued at approximately $7,936,000. Nordea Investment Management AB bought a new stake in shares of Sotera Health during the 4th quarter worth approximately $1,908,000. Exchange Traded Concepts LLC bought a new stake in shares of Sotera Health during the 4th quarter worth approximately $7,739,000. Retirement Systems of Alabama lifted its stake in shares of Sotera Health by 16.9% during the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock worth $4,391,000 after acquiring an additional 35,974 shares during the last quarter. Finally, Hudson Bay Capital Management LP bought a new position in shares of Sotera Health in the third quarter worth about $3,932,000. 91.03% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Piper Sandler restated an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Barclays lowered their price objective on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Weiss Ratings downgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Thursday, May 21st. Finally, Citigroup boosted their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, February 24th. Eight investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $20.29.

Insider Transactions at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 15.36% of the company’s stock.

Sotera Health Price Performance

NASDAQ SHC opened at $16.53 on Wednesday. The firm’s fifty day simple moving average is $15.48 and its two-hundred day simple moving average is $16.38. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56. Sotera Health Company has a 12-month low of $10.80 and a 12-month high of $19.85. The firm has a market capitalization of $4.71 billion, a P/E ratio of 40.32 and a beta of 1.79.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. During the same period in the prior year, the company posted $0.14 EPS. The firm’s quarterly revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Analysts forecast that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.